Company page

Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp. (DMAA) is a public company focused on the pharmaceutical sector in the American market. With a market capitalization of approximately $257.6 million, DMAA aims to identify and acquire businesses within the drug manufacturing industry. The company is committed to promoting domestic production of pharmaceuticals in the United States.